104 related articles for article (PubMed ID: 8818390)
1. Detection of colon cancer by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
Merimsky O; Duetsch M; Tirosh R; Wohl I; Weinreb A; Chaitchik S
Cancer Detect Prev; 1996; 20(4):300-7. PubMed ID: 8818390
[TBL] [Abstract][Full Text] [Related]
2. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S
Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078
[TBL] [Abstract][Full Text] [Related]
3. An approach for high sensitivity detection of prostate cancer by analysis of changes in structuredness of the cytoplasmic matrix of lymphocytes specifically induced by PSA-ACT.
Klein O; Lin S; Embon O; Sazbon A; Zidan J; Kook AI
J Urol; 1999 Jun; 161(6):1994-6. PubMed ID: 10332488
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
[TBL] [Abstract][Full Text] [Related]
5. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
7. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
Lohsiriwat V; Thavichaigarn P; Awapittaya B
J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
[TBL] [Abstract][Full Text] [Related]
8. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in the diagnosis of colorectal carcinoma.
Hocking GR; Rolland JM; Nairn RC; Pihl E; Cuthbertson AM; Hughes ES; Johnson WR
J Natl Cancer Inst; 1982 Apr; 68(4):579-83. PubMed ID: 6951073
[TBL] [Abstract][Full Text] [Related]
10. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
11. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients.
Douard R; Le Maire V; Wind P; Sales JP; Dumas F; Fayemendi L; Landi B; Benichou J; Cugnenc PH; Gayral F; Loric S
Surgery; 2001 May; 129(5):587-94. PubMed ID: 11331451
[TBL] [Abstract][Full Text] [Related]
13. An approach for high sensitivity detection of breast cancer by analysis of changes in structure of the cytoplasmic matrix of lymphocytes specifically induced by a specific breast tumour antigen (MUC-l/SEC).
Klein O; Linn S; Hadari A; Davidson C; Eitan A; Zidan J; Kook AI
Breast; 2002 Apr; 11(2):137-43. PubMed ID: 14965660
[TBL] [Abstract][Full Text] [Related]
14. Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer.
Basoglu M; Yildirgan MI; Taysi S; Yilmaz I; Kiziltunc A; Balik AA; Celebi F; Atamanalp SS
J Surg Oncol; 2003 Jul; 83(3):180-4. PubMed ID: 12827689
[TBL] [Abstract][Full Text] [Related]
15. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
16. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivity, specificity and prognostic value of CEA in colorectal cancer: results of a Tunisian series and literature review].
Bel Hadj Hmida Y; Tahri N; Sellami A; Yangui N; Jlidi R; Beyrouti MI; Krichen MS; Masmoudi H
Tunis Med; 2001; 79(8-9):434-40. PubMed ID: 11774785
[TBL] [Abstract][Full Text] [Related]
18. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
19. Different distribution of Dukes' stage between proximal and distal colorectal cancer.
Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K
Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728
[TBL] [Abstract][Full Text] [Related]
20. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
